Basel Medical Group Files to Sell Up to 6M Units with Warrants
BMGL is trading near its 52-week low of $3.9 (11% above the low) on light trading volume (0.2× avg).
Summary
Basel Medical Group filed an F-1 to sell up to 6 million units, each consisting of shares and warrants that could add up to 12 million shares total. The offering is highly dilutive relative to the company's small market cap. This follows a reverse split in June and a recent board shakeup. The filing comes amid a securities class action lawsuit disclosed in August.
At the time of this announcement, BMGL was trading at $4.31 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $6.7M. The 52-week trading range was $3.90 to $25.80. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.